- Aptar CSP Technologies Documents
- Aptar CSP Technologies Locations
- Aptar CSP Technologies News
- Aptar CSP Technologies Videos
- CSP Technologies, Inc. Web Index
- Maxwell Chase Technologies
If this is your company, CONTACT US to activate Packbase™ software to build your portal.
Aptar CSP Technologies,a leader in material science and active packaging solutions (part of AptarGroup, Inc.), announced its Activ-Film technology protects two new at-home COVID-19 tests that recently received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA).
The tests were developed by a leading manufacturer of diagnostic healthcare solutions and offer prescription and OTC (Over the Counter) COVID-19 at-home testing options without the need to visit a doctor’s office
Aptar CSP’s Activ-Film technology is integrated into the dipstick of the diagnostic kits to protect against moisture and other environmental conditions that could otherwise impact test accuracy. Activ-Film leverages Aptar’s proprietary 3-Phase Activ-Polymer platform technology, which provides a broad spectrum of customized and highly-engineered solutions in a variety of configurations, such as Activ-Vial for housing diagnostics strips and dipsticks, and Activ-Tab, which is integrated within diagnostic cassettes.
This material science-based active packaging technology currently protects a range of lateral flow, molecular, and electrochemical diagnostic test kits on the market today, including Quidel Corporation’s QuickVue Influenza and COVID-19 tests.
“As we continue to navigate through the COVID-19 crisis, this game-changing solution will help meet the urgent demand for COVID-19 testing in communities around the world,” said Badre Hammond, Vice President Commercial Operations, Aptar CSP Technologies. “We are committed to leveraging our material science expertise to enable our partners to meet the ongoing need for innovative healthcare solutions that help improve and save lives. This is another example of the value we bring to the market when sensitive diagnostic elements need protection.”
More information about the new at-home COVID-19 tests is available on the FDA website.
Aptar’s Activ-Film Technology Selected to Protect New SARS Rapid Antigen Test for COVID-19 Diagnosis
AptarGroup has announced that its Activ-Film technology was selected to protect a new SARS Rapid Antigen test for COVID-19 that recently received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA).
Aptar CSP Technologies launches fully integrated active packaging solution combining moisture adsorption and oxygen scavenging properties
Aptar CSP Technologies is launching the first-of-its kind combination oxygen scavenging and moisture adsorption active packaging solution. This new technology utilizes the company’s patented 3-phase Activ-Polymer platform within its Activ-Film product configuration.
Aptar CSP Technologies, part of Aptar Group, Inc, has launched a complete solution service offering focusing on de-risking development and insuring speed-to-market. The new Xcelerate Development Services optimizes the active packaging development process through end-to-end expert insight, resulting in expedited speed-to-market.
Aptar CSP presents 'rethinking oral solid dose packaging' webinar
Aptar CSP Technologies – a leader in active packaging solutions that ensure product protection, enhance brand recognition and improve use experiences, and part of AptarGroup Inc – is presenting its Activ-Blister Solutions for the protection of moisture and oxygen-sensitive tablets and capsules, alongside FreeThink Technologies and its ASAPprime technology for accelerated shelf-life determination. The combination is a “right the first time” approach to stability challenges and blister package design that virtually eliminates protracted testing and costly reformulations.
CSP Technologies, Inc. Introduces Material Science Lab in Newly Expanded Manufacturing Space
CSP Technologies, Inc. – a leader in designing and producing packaging solutions that ensure product protection, enhance brand recognition and improve consumer experiences – has completed a 100,000-square-foot facility expansion at its Auburn, Alabama headquarters, and is currently transitioning several new and enhanced capabilities into the ample space.
CSP Technologies, Inc. expanding Auburn, AL facility for increased manufacturing & warehousing space
CSP Technologies, Inc. is expanding its Auburn, Alabama manufacturing and warehousing capacity by 110,000 square feet. Construction of the new structure, located adjacent to the existing headquarters, is currently underway.
At Smart Packaging Conference in Germany, CSP Technologies, Inc. to present approach for enhancing shelf life for transdermal & oral solid dose drugs
François Bidet, Director of Business Development EMEA, CSP Technologies, to discuss benefits of company's patented engineered Activ-Polymer technology and Activ-Film materials for Headspace Management.
CSP Technologies' focus for enhancing the shelf life for transdermal and oral solid dose drugs
Despite being two very different drug delivery platforms, oral solid doses and transdermal patches can face similar packaging headspace challenges that impact shelf life; besides moisture and oxygen ingress, exposure to certain conditions can lead to the formation of volatile organic compounds (VOCs) and other gases that, in turn, may interact with drug products and capsules, adversely impacting their stability.
At IPA’s Stability Program Conference, CSP Technologies, Inc. to present approach for enhancing shelf life for transdermal & oral solid dose drugs
Craig Voellmicke, VP of Business Development, to discuss benefits of CSP’s patented engineered Activ-Polymer™ solutions for Headspace management at June conference in Montreal.
CSP takes its desiccant packaging concepts into new spaces, including new pharma blisters with desiccant foils
François Bidet, CSP's Director of Business Development for EMEA, sat down with us recently in order to review some of the company's latest offerings. Of special note is the company's upcoming Activ-Blister concept, which takes desiccant foils manufactured by the firm and applies them to blister packaging for pills and capsules.
CSP Technologies to showcase expanded options for Activ-Seal closures with desiccant technology
The original Activ-Seal closure incorporates moisture and gas scavenging technology which is press-fit into an induction-sealed, tamper-evident screw cap. Built directly into screw cap closure, effortless insertion technology controls levels of moisture and volatile off-gasses, helping to ensure product stability and extend shelf life.
CSP Technologies, Inc. develops Pharmapuck scavenging devices, an integrated solution for oral solid dose products
CSP Technologies, Inc. – a leader in packaging solutions that ensure product protection, enhance brand recognition and improve consumer experiences – has introduced a new active scavenging solution that can be integrated directly into primary containers to protect oral solid dose (OSD) products from moisture and oxygen absorption.
CSP Technologies, Inc. introduces Activ-Blister solutions for customizable product protection at Interphex NYC
Packaging innovation protects solid dose pharmaceuticals from moisture, oxygen and odors while enhancing shelf life, eliminating purging/secondary packaging and enabling a move from bottles to blisters.
- Bianka Cramblit
- Product Info
- Created 28 Apr 2021
- Modified 28 Apr 2021
- Hits 178